scispace - formally typeset
Journal ArticleDOI

The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes

Reads0
Chats0
TLDR
complexes with arene = tha, thn, dha, ind and p-terp, and deprotonated bipyridinediol (bipy(OH)O) as chelating ligands, exhibited significant cytotoxicity toward A2780 human ovarian and A549 human lung cancer cells.
Abstract
The synthesis and characterization of ruthenium(II) arene complexes [(η6-arene)Ru(N,N)Cl]0/+, where N,N = 2,2′-bipyridine (bipy), 2,2′-bipyridine-3,3′-diol (bipy(OH)2) or deprotonated 2,2′-bipyridine-3,3′-diol (bipy(OH)O) as N,N-chelating ligand, arene = benzene (bz), indan (ind), biphenyl (bip), p-terphenyl (p-terp), tetrahydronaphthalene (thn), tetrahydroanthracene (tha) or dihydroanthracene (dha), are reported, including the X-ray crystal structures of [(η6-tha)Ru(bipy)Cl][PF6] (1), [(η6-tha)Ru(bipy(OH)O)Cl] (2) and [(η6-ind)Ru(bipy(OH)2)Cl][PF6] (8). Complexes 1 and 2 exibit CH (arene)/π (bipy or bipy(OH)O) interactions. In the X-ray structure of protonated complex 8, the pyridine rings are twisted (by 17.31°). In aqueous solution (pH = 2−10), only deprotonated (bipy(OH)O) forms are present. Hydrolysis of the complexes was relatively fast in aqueous solution (t1/2 = 4−15 min, 310 K). When the arene is biphenyl, initial aquation of the complexes is followed by partial arene loss. Complexes with arene =...

read more

Citations
More filters
Journal ArticleDOI

Arene ruthenium complexes as anticancer agents

TL;DR: Neutral or cationic arene ruthenium complexes providing both hydrophilic as well as hydrophobic properties due to the robustness of the rUThenium-arene unit hold a high potential for the development of metal-based anticancer drugs.
Journal ArticleDOI

Organometallic Half-Sandwich Iridium Anticancer Complexes

TL;DR: The hydrophobicity and intercalative ability of Cp (xph) and Cp(xbiph) make a major contribution to the anticancer potency of their Ir(III) complexes.
Book ChapterDOI

Activation Mechanisms for Organometallic Anticancer Complexes

TL;DR: In this article, the activation of metallocenes, arene, alkyl or aryl complexes by hydrolysis, and metal- or ligand-based redox reactions is discussed.
Journal ArticleDOI

Anticancer activity of multinuclear arene ruthenium complexes coordinated to dendritic polypyridyl scaffolds

TL;DR: The rational development of multinuclear arene ruthenium complexes (arene = p-cymene, hexamethylbenzene) from generation 1 (G1) and generation 2 (G2) of 4-iminopyridyl based poly(propyleneimine) dendrimer scaffolds of the type DAB-(NH2)n (n = 4 or 8, DAB = diaminobutane) has been accomplished in order to exploit the enhanced permeability and retention' (EPR) effect that allows
References
More filters
Journal ArticleDOI

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

TL;DR: The SRB assay provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-volume, automated drug screening.
Journal ArticleDOI

Chemistry with ADF

TL;DR: The “Activation‐strain TS interaction” (ATS) model of chemical reactivity is reviewed as a conceptual framework for understanding how activation barriers of various types of reaction mechanisms arise and how they may be controlled, for example, in organic chemistry or homogeneous catalysis.
Journal ArticleDOI

A critical account on π–π stacking in metal complexes with aromatic nitrogen-containing ligands

TL;DR: In this paper, a geometrical analysis of π-π stacking in metal complexes with aromatic nitrogen-containing ligands was performed based on a Cambridge Structural Database search and on X-ray data of examples.
Journal ArticleDOI

Relativistic regular two‐component Hamiltonians

TL;DR: In this article, potential-dependent transformations are used to transform the four-component Dirac Hamiltonian to effective two-component regular Hamiltonians, which already contain the most important relativistic effects, including spin-orbit coupling.
Related Papers (5)